Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

Clariane Shares Slide 2.85% Approaching Critical Support at €3.40

Shares of the European dependency care specialist dropped 2.85% this Thursday, to €3.61, amid a significant downturn in the CAC 40. The decline brings the share price close to a closely watched technical threshold, with the publication of the quarterly revenue expected in three weeks.


Clariane Shares Slide 2.85% Approaching Critical Support at €3.40

Market Context and Company Performance

During the session, the CAC 40 fell by 1.25% to around 7,881 points, while the SBF 120 dropped 1.26%. In this tense atmosphere, Clariane intensified the downward movement with a decline of 2.85% from the previous day's close, to €3.72. The stock now shows a decrease of 8.24% over three months and 14.62% over a year, confirming an unfavorable long-term trend despite a slight rebound of 4.52% observed over the last seven days. No specific news about the group was released this Thursday. The next dates on the financial calendar are the communication of the first quarter 2026 revenue, scheduled for April 23, followed by the general assembly planned on May 12. These events are the next catalysts that could alter the stock's trajectory.

Technical Analysis

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Graphically, the price of €3.61 is significantly below the 50-day moving average, which stands at €3.82, and even more so from the 200-day moving average at €4.14. This gap indicates a medium-term bearish dynamic. The stock is approaching the support identified at €3.40; a downward breach of this level could increase selling pressure, while the resistance at €4.07 remains distant from the current price. The RSI, an indicator measuring the speed and magnitude of price changes, remains at 51, in a neutral zone. This level indicates neither overbuying nor overselling, but reflects a lack of directional conviction in the short term. The negative beta of -0.37 assigned to the stock also indicates an inverse correlation with the market, which makes its behavior atypical compared to the overall Paris market. However, this characteristic did not play out this Thursday, as the stock declined more sharply than the reference index.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit